They also complement medication-based treatment with behavior counseling, dietary recommendations, and other wellness resources, ensuring a holistic approach to weight loss
The medication works by mimicking the incretin hormone GLP-1, which enhances glucose-dependent insulin secretion, suppresses glucagon release, and slows gastric emptying
Ishihara color vision testing was normal, and systemic workup revealed no symptoms or laboratory evidence, i.e., C-reactive protein, thrombocytes and sedimentation rate, suggestive of giant cell arteritis (GCA)
Tracking also helps distinguish between true hunger (a physiological signal that the medication is no longer suppressing appetite) and habitual eating patterns, emotional eating, or environmental triggers
For weight management, Zepbound is indicated for adults with a BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity